Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Double-Blind Placebo-Controlled Period	STARTED	Early Start: GA 40 mg / GA 40 mg	943
Double-Blind Placebo-Controlled Period	STARTED	Delayed Start: Placebo / GA 40 mg	461
Double-Blind Placebo-Controlled Period	COMPLETED	Early Start: GA 40 mg / GA 40 mg	859
Double-Blind Placebo-Controlled Period	COMPLETED	Delayed Start: Placebo / GA 40 mg	430
Double-Blind Placebo-Controlled Period	NOT COMPLETED	Early Start: GA 40 mg / GA 40 mg	84
Double-Blind Placebo-Controlled Period	NOT COMPLETED	Delayed Start: Placebo / GA 40 mg	31
Open-Label Period	STARTED	Early Start: GA 40 mg / GA 40 mg	834
Open-Label Period	STARTED	Delayed Start: Placebo / GA 40 mg	419
Open-Label Period	COMPLETED	Early Start: GA 40 mg / GA 40 mg	580
Open-Label Period	COMPLETED	Delayed Start: Placebo / GA 40 mg	261
Open-Label Period	NOT COMPLETED	Early Start: GA 40 mg / GA 40 mg	254
Open-Label Period	NOT COMPLETED	Delayed Start: Placebo / GA 40 mg	158

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01067521/flow